Coherus BioSciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Coherus BioSciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $257,244,000. The net income raised on -$237,892,000 and profit margin reached -92%. Total operating expenses were $301,451,000.
Profit Margin
| 2014 | 31.10M | -87.13M | -280.12% |
|---|---|---|---|
| 2015 | 30.04M | -223.26M | -743.18% |
| 2016 | 190.10M | -127.33M | -66.98% |
| 2017 | 1.55M | -238.17M | -15306.56% |
| 2018 | 1.55M | -209.33M | -13453.66% |
| 2019 | 356.07M | 89.83M | 25.23% |
| 2020 | 475.82M | 132.24M | 27.79% |
| 2021 | 326.55M | -306.32M | -93.81% |
| 2022 | 211.04M | -326.62M | -154.77% |
| 2023 | 257.24M | -237.89M | -92.48% |
CHRS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 257.24M | 211.04M | 326.55M | 475.82M | 356.07M | 1.55M | 1.55M | 190.10M | 30.04M | 31.10M |
Cost of revenue | 162.78M | 70.08M | 57.59M | 37.66M | 17.07M | 0 | 160.53M | 0 | 212.68M | 78.22M |
Gross profit | 94.46M | 140.95M | 268.96M | 438.15M | 338.99M | 1.55M | -158.97M | 190.10M | -182.63M | -47.11M |
Operating exp. | ||||||||||
Research and development | 109.43M | 199.35M | 363.10M | 142.75M | 94.18M | 110.23M | 162.38M | 254.44M | 213.06M | 78.22M |
Selling and marketing | 0 | 10.5M | 8.7M | 3.8M | 4.5M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 301.45M | 397.83M | 532.81M | 281.83M | 231.22M | 204.41M | 233.69M | 306.03M | 249.10M | 95.78M |
Operating income | -203.19M | -256.88M | -263.85M | 156.31M | 107.76M | -204.41M | -232.13M | -115.93M | -219.06M | -64.68M |
Other income (expenses), net | -35.07M | -34.87M | -23.24M | -20.61M | -14.99M | 4.69M | -6.15M | -3.87M | -4.87M | -22.49M |
Income before tax | -238.27M | -291.75M | -287.1M | 135.70M | 92.77M | -209.40M | -238.28M | -127.78M | -223.93M | -87.17M |
Income tax expense | -380K | 34.87M | 19.22M | 3.46M | 2.94M | 4.69M | 9.44M | 656K | -7.35M | -15.41M |
Net income | -237.89M | -326.62M | -306.32M | 132.24M | 89.83M | -209.33M | -238.17M | -127.33M | -223.26M | -87.13M |
Earnings per share | ||||||||||
Basic EPS | -2.53 | -4.21 | -4.06 | 1.85 | 1.29 | -3.22 | -4.48 | -3.04 | -6.01 | -10.64 |
Diluted EPS | -2.53 | -4.21 | -4.06 | 1.62 | 1.23 | -3.22 | -4.48 | -3.04 | -6.01 | -10.64 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |